Clinical Trial Update: Beta Blocker for Chronic Wound Healing [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating an unspecified beta blocker for chronic wound healing has been terminated. The study enrolled patients with ulcers and burns…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Burns
• Ulcers

Drugs mentioned

• Beta blocker (unspecified) (beta blocker)

Snippet

Sponsor: University of California, Davis | Conditions: Ulcer, Burns | Phase 2 | Status: TERMINATED